432 related articles for article (PubMed ID: 23139636)
1. Regulation of the SRC family kinases by Csk.
Okada M
Int J Biol Sci; 2012; 8(10):1385-97. PubMed ID: 23139636
[TBL] [Abstract][Full Text] [Related]
2. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
[TBL] [Abstract][Full Text] [Related]
3. Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394.
Bougeret C; Delaunay T; Romero F; Jullien P; Sabe H; Hanafusa H; Benarous R; Fischer S
J Biol Chem; 1996 Mar; 271(13):7465-72. PubMed ID: 8631775
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Csk-mediated down-regulation of Src family tyrosine kinases in epidermal growth factor signaling.
Matsuoka H; Nada S; Okada M
J Biol Chem; 2004 Feb; 279(7):5975-83. PubMed ID: 14613929
[TBL] [Abstract][Full Text] [Related]
5. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
Chong YP; Mulhern TD; Cheng HC
Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
[TBL] [Abstract][Full Text] [Related]
6. Early emergence of negative regulation of the tyrosine kinase Src by the C-terminal Src kinase.
Taskinen B; Ferrada E; Fowler DM
J Biol Chem; 2017 Nov; 292(45):18518-18529. PubMed ID: 28939764
[TBL] [Abstract][Full Text] [Related]
7. Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling.
Rubbi L; Titz B; Brown L; Galvan E; Komisopoulou E; Chen SS; Low T; Tahmasian M; Skaggs B; Müschen M; Pellegrini M; Graeber TG
Sci Signal; 2011 Mar; 4(166):ra18. PubMed ID: 21447799
[TBL] [Abstract][Full Text] [Related]
8. Identification of a new interaction mode between the Src homology 2 domain of C-terminal Src kinase (Csk) and Csk-binding protein/phosphoprotein associated with glycosphingolipid microdomains.
Tanaka H; Akagi K; Oneyama C; Tanaka M; Sasaki Y; Kanou T; Lee YH; Yokogawa D; Dobenecker MW; Nakagawa A; Okada M; Ikegami T
J Biol Chem; 2013 May; 288(21):15240-54. PubMed ID: 23548896
[TBL] [Abstract][Full Text] [Related]
9. Coupled motions in the SH2 and kinase domains of Csk control Src phosphorylation.
Wong L; Lieser SA; Miyashita O; Miller M; Tasken K; Onuchic JN; Adams JA; Woods VL; Jennings PA
J Mol Biol; 2005 Aug; 351(1):131-43. PubMed ID: 16002086
[TBL] [Abstract][Full Text] [Related]
10. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
[TBL] [Abstract][Full Text] [Related]
11. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
[TBL] [Abstract][Full Text] [Related]
12. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
[TBL] [Abstract][Full Text] [Related]
13. Mammalian Pragmin regulates Src family kinases via the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif that is exploited by bacterial effectors.
Safari F; Murata-Kamiya N; Saito Y; Hatakeyama M
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14938-43. PubMed ID: 21873224
[TBL] [Abstract][Full Text] [Related]
14. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
[TBL] [Abstract][Full Text] [Related]
15. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
Fan G; Aleem S; Yang M; Miller WT; Tonks NK
J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
[TBL] [Abstract][Full Text] [Related]
16. Distal loop flexibility of a regulatory domain modulates dynamics and activity of C-terminal SRC kinase (csk).
Barkho S; Pierce LC; McGlone ML; Li S; Woods VL; Walker RC; Adams JA; Jennings PA
PLoS Comput Biol; 2013; 9(9):e1003188. PubMed ID: 24039559
[TBL] [Abstract][Full Text] [Related]
17. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
18. C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinases.
Chong YP; Chan AS; Chan KC; Williamson NA; Lerner EC; Smithgall TE; Bjorge JD; Fujita DJ; Purcell AW; Scholz G; Mulhern TD; Cheng HC
J Biol Chem; 2006 Nov; 281(44):32988-99. PubMed ID: 16959780
[TBL] [Abstract][Full Text] [Related]
19. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
Chong YP; Ia KK; Mulhern TD; Cheng HC
Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
[TBL] [Abstract][Full Text] [Related]
20. SH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding.
Brian BF; Sjaastad FV; Freedman TS
Sci Rep; 2022 Apr; 12(1):5875. PubMed ID: 35393453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
